SCM
BMRN icon

Sterling Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sterling Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Sell
6,378
-4,893
-43% -$285K 0.01% 914
2025
Q4 		$670K Sell
11,271
-484
-4% -$26.4K 0.01% 801
2025
Q3 		$637K Sell
11,755
-900
-7% -$51.5K 0.01% 824
2025
Q2 		$696K Buy
12,655
+2,157
+21% +$127K 0.01% 772
2025
Q1 		$742K Sell
10,498
-694
-6% -$46.7K 0.01% 695
2024
Q4 		$736K Buy
11,192
+3,993
+55% +$267K 0.01% 730
2024
Q3 		$506K Buy
+7,199
New +$602K 0.01% 848
2016
Q2 		– Sell
-2,445
Closed -$202K – 933
2016
Q1 		$202K Buy
+2,445
New +$199K ﹤0.01% 864

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return